"Drug Name","Active Ingredient","Form;Route","Appl. No.","Company","Date","Link"
"Abacavir and LAmivudine","Abacavir Sulfate;Lamivudine","TABLET;ORAL","204311","MYLAN LABORATORIES LIMITED","12/22/2023","https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204311s000lbl.pdf#page=34"
"Abilify","Aripiprazole","TABLET;ORAL","021436","OTSUKA","11/30/2022","https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021436s048lbl.pdf#page=47"
"Abilify","Aripiprazole","SOLUTION;ORAL","021713","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
"Abilify","Aripiprazole","TABLET, ORALLY DISINTEGRATING;ORAL","021729","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
"Abilify","Aripiprazole","INJECTABLE;INTRAMUSCULAR","021866","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
"Abilify Maintena Kit","Aripiprazole","FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","202971","OTSUKA PHARM CO LTD","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202971s013lbl.pdf#page=52"
